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Abstract
Objective: Mitral regurgitation is a frequent finding in patients with end-stage cardiomyopathy predicting poor survival. Conventional
treatment consists medical treatment or cardiac transplantation. However, despite severely decreased left ventricular function, mitral
annuloplasty may improve survival and reduce the need for allografts. Methods: From January 1996 to July 2002, 121 patients with severe
end-stage dilated (DCM) or ischemic cardiomyopathy (ICM), mitral regurgitation $2, and left ventricular ejection fraction #30%
underwent mitral valve annuloplasty using a flexible posterior ring. DCM was diagnosed in 30 patients (25%), whereas ICM was found in 91
patients (75%). Concomitant tricuspid valve repair was performed in 14 (46.6%) patients in the DCM, and in 11 (12%) in the ICM group
ðP ¼ 0:0001Þ, coronary artery bypass grafting in three (10%) in the DCM, and in 78 patients (86%) in the ICM group ðP , 0:00001Þ. The
mean follow-up time was 567 ^ 74 days in the DCM and 793 ^ 63 days in the ICM group (ns). Results: Early mortality was 6.6% (8/121),
and was equal for both groups. Improvement in NYHA class (DCM 3.3 þ 0.1–1.8 ^ 0.16; ICM from 3.2 þ 0.04 to 1.7 ^ 0.07) were equal
between groups after 1 year. Seventeen (15%) late deaths occurred during the follow-up period. There was no difference in the 2-year
actuarial survival between groups (DCM/ICM 0.93/0.85). Risk factors for mitral reconstruction failure, defined as regurgitation $2 after 1
year, were preoperative NYHA IV in the DCM group ðP ¼ 0:03Þ, a preoperative posterior infarction ðP ¼ 0:025Þ, decreased left ventricular
function ðP ¼ 0:043Þ, larger ring size ðP ¼ 0:026Þ and preoperative renal failure ðP ¼ 0:05Þ in the ICM group. Risk factors for death were
larger ring size ðP ¼ 0:02Þ and an increased LVEDD ðP ¼ 0:027Þ in the DCM group and the postoperative use of IABP ðP ¼ 0:002Þ, renal
failure ðP ¼ 0:001Þ, and a larger preoperative LVESD ðP ¼ 0:035Þ in the ICM group. Conclusion: Mitral reconstruction with a posterior
annuloplasty using a flexible ring is effective in patients with severely depressed left ventricle function and has an acceptable operative
mortality. Mid-term results are superior to medical treatment alone and comparable to cardiac transplantation.
q 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Mitral regurgitation in patients with cardiomyopathy and
severe left ventricular dysfunction remains one of the most
challenging problems in cardiac surgery. Volume overload
secondary to mitral regurgitation further increases ventri-
cular dilatation and vice versa the degree of mitral
regurgitation through subsequent annular dilatation. This
results in a ‘vicious cycle’ ending in severe mitral
regurgitation in the presence of severe left ventricular
dysfunction [1].
In patients with end stage cardiomyopathy mitral
regurgitation clearly has a negative impact on survival
being as low as 30% after 1 year [2–4]. Once medical
therapy has been maximized, cardiac transplantation may be
the only option available to this group of patients. Given the
limitations imposed on cardiac transplantation due to organ
shortage, age, and its restricted applicability in patients with
concomitant extra-cardiac diseases, mitral reconstruction
may represent a valuable alternative for these patients.
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Historically, operative mortality was increased in patients
with severe ventricular systolic dysfunction undergoing
mitral reconstruction [5]. Due to improvements in surgical
techniques, myocardial protection, anaesthetic management
and postoperative intensive care treatment mitral valve
reconstruction has become feasible even in patients with
severe decreased left ventricular function, including those
with the need for concomitant coronary artery revascula-
rization, tricuspid valve repair or arrhythmia surgery for
chronic atrial fibrillation [6,7].
The present study analyses the 6-year results of 121
patients with dilated or ischemic cardiomyopathy, and a
preoperative left ventricular ejection fraction #30%,
undergoing mitral valve reconstruction with a flexible
posterior band.
2. Patient and methods
2.1. Study group and patient characteristics
Between January 1996 and July 2002, 121 patients with
idiopathic cardiomyopathy (DCM) or ischemic cardiomyo-
pathy (ICM) and mitral regurgitation (MR) $28 were
referred for surgery. All patients had severe left ventricular
systolic dysfunction defined as left ventricular ejection
fraction (LVEF) being equal or less than 30% on
echocardiography and angiography. Patient characteristics
are summarized in Table 1.
The etiology of MR was based on preoperative
echocardiographic and angiographic findings, presence of
posterior wall infarction, operative findings and pathologic
examination. All patients with ICM and MR had a history of
previous myocardial infarction. Coronary artery bypass
grafting had already been performed in 15/91 (16.5%) of
these patients. All patients received maximal medical
therapy for congestive heart failure, including digoxine,
angiotensin converting enzyme inhibitors, diuretics, and
beta blockers. Furthermore, all patients were hospitalized at
least once prior to surgery due to congestive heart failure
and/or unstable angina. The mean preoperative NHYA
functional class for DCM patients was 3.3 ^ 0.1 and
3.2 ^ 0.04 (ns) for ICM patients.
In the DCM group, atrial fibrillation was diagnosed in
11/30 (36.6%) patients, 4/30 (13.4%) were permanently
paced, and 15/30 (50%) patients were in sinus rhythm. In the
ICM group, 18/91 (20%) patients were in atrial fibrillation,
9/91 (10%) were permanently paced, and 64/91 (70%)
patients were in sinus rhythm.
2.2. Follow up
All patients were examined in the outpatient department
1 year after surgery. A standard questionnaire was used to
evaluate clinical symptoms. The following diagnostic
procedures were performed: physical examination, electro-
cardiography, and transthoracic echocardiography (TTE).
Follow-up was complete for 100% of DCM and 93% of
ICM patients. Postoperative readmission for congestive
heart failure and cause of death were documented. In July
2002 all patients were contacted again by telephone to
evaluate if they are alive. This second follow-up was 100%
complete for DCM patients and 98% for ICM patients. The
mean follow-up time (July 2002) was 567 ^ 74 days for
DCM and 793 ^ 63 days ICM patients (ns).
2.3. Echocardiography
Preoperative TTE was performed in all patients by the
same observer. At 1-year follow-up 84% of surviving
patients had TTE again in our laboratory whereas the TTE
videos of 12% of patients were sent to us from external
cardiologists for evaluation. Two-dimensional and Doppler
transthoracic echocardiography was performed using a
Hewlett–Packard Sonos 4500 or 5500 (Hewlett-Packard,
Andover, MA, USA) machine. Standard parasternal and
apical images were obtained and left ventricular function
and mitral insufficiency were assessed visually. In 5/121
(4%) patients (all ICM patients) it was not possible to
receive a TTE videotape after 1 year.
2.4. Surgical techniques
Median sternotomy was used for first procedures and
right lateral thoracotomy in case of three reoperations.
Standard normothermic cardiopulmonary bypass (CPB)
techniques with ante- and retrograde cold blood cardiople-
gia was used in most patients. Hypothermic cardiopulmon-
ary bypass without aortic cross-clamping was performed in
five patients (all reoperation cases). In case of coronary
artery bypass grafting, coronary anastomoses were per-
formed first, followed by reconstruction of the mitral valve
through a left atrial or transseptal approach. In all patients
implantation of a flexible posterior ring (Carbo Medics
Annuloflex; Baxter Cosgrove or SJM Tailor, USA) was
used to repair the mitral valve. The mean ring size was
27.7 ^ 1.3 in DCM group, and 28 ^ 1.9 in ICM group (ns).
Mitral valve repair techniques used in addition to posterior
flexible ring annuloplasty were in accordance to the
pathology of the mitral valve leaflet and included posterior
leaflet quadrangular resection in three patients (prolaps due
Table 1
Patient characteristics
Characteristics DCM Group
(n ¼ 30)
ICM Group
(n ¼ 91)
P-value
Age 67.5 ^ 1.2 66 ^ 0.8 NS
Gender (male) 15 63 0.05
Hypertension (yes) 12 72 0.0003
Diabetes (yes) 7 27 NS
Renal Insufficiency (yes) 11 28 NS
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to elongated infarcted papillary muscle) and chordal transfer
in two patients. Concomitant tricuspid valve repair was
performed in 14/30 (46.6%) patients in the DCM, and in
11/91 (12%) patients in the ICM group ðP ¼ 0:0001Þ.
Concomitant CABG with one anastomosis was performed
in 3/30 (10%) patients with DCM, and in 78/91 (86%)
patients with ICM. Mean number of distal anastomosis was
2.4 ^ 0.15 per patient in the ICM group. The mean duration
of cardiopulmonary bypass/aortic cross clamp time in DCM
group was 91 ^ 4.7 min/51 ^ 3.6 min and in ICM group it
was 126 ^ 4.7 min/76.3 ^ 3.3 min, respectively
ðP , 0:00001Þ. Other concomitant procedures were aortic
valve replacement (DCM 5/30pts; ICM 4/91 pts), aneu-
rysmectomy (ICM 10/91 pts) and biventricular pacemaker
implantation (DCM 5/30 pts; ICM 1/91 pts) ðP ¼ 0:002Þ.
2.5. Statistical analysis
The pre-, intra- and postoperative parameters were
entered in a database and analysed. All calculations were
performed using a commercial available statistical package
(SPSS 9.0 for windows). The distribution of continuous
variables is expressed as mean ^ standard error and
comparison was tested by two tailed t-test (Mann–Whitney
test). Categorical variables were compared by Chi-square
test and Fisher’s Exact test as appropriate. Preoperative and
intraoperative variables were analysed for their relationship
with postoperative mortality and morbidity and comparison
was made between the groups. Survival was calculated
according to Kaplan–Meier analysis.
3. Results
3.1. Mortality
Eight of 121 (6.6%) patients died within 30 days after
surgery. There were 2/30 (6.6%) deaths in the DCM and
6/91 (6.6%) in the ICM group (ns). Reason for death was
low-cardiac output in all patients except in one who died
from perioperative cerebrovascular infarction.
There were 17/113 (15%) deaths during the follow-up
period, 5/28 (18%) in the DCM, and 12/85 (14%) in the ICM
group. In all DCM patients, death during follow-up was
entirely due to progression of myocardial failure. In ICM
patients, three causes of death were due to non-cardiac
diseases and unrelated to cardiac surgery. One patient died
of progression of a carcinoma disease, one of gastrointes-
tinal bleeding and one because of cerebrovascular infarc-
tion. Actuarial survival of DCM and ICM patients is
depicted in Fig. 1.
Risk factors for early and late death for the DCM group
were a larger annuloplasty ring ðP ¼ 0:021Þ and a
preoperative larger LVEDD ðP ¼ 0:027Þ whereas for the
ICM group risk factors were preoperative larger LVESD
ðP ¼ 0:035Þ, preoperative renal insufficiency ðP ¼ 0:0014Þ
and postoperative use of IABP ðP ¼ 0:0022Þ.
3.2. Postoperative course
Inotrops to wean patients from cardiopulmonary bypass
were used in 14/30 (47%) DCM and 47/91 (52%) ICM
patients. In addition, intra-aortic balloon pumping was
necessary in 7/91 (7.7%) ICM patients. The mean length of
intensive care stay was 3.0 ^ 0.4 days in DCM group, and
4.5 ^ 0.7 days in ICM group, and the mean total length of
hospital stay was 13.7 ^ 6.5 days in DCM group and
12.4 ^ 6.2 days in ICM group. Postoperative dialysis was
necessary in 2/30 (6.7%) DCM patients and in 6/91 (6.6%)
ICM patients. Pneumonia occurred in 10/91 (11%) and
stroke in 4/91 (4.4%) ICM patients.
3.3. Follow-up
After one year NYHA functional class improved from
3.3 ^ 0.1 to 1.8 ^ 0.2 in the DCM, and from 3.2 ^ 0.04 to
1.7 ^ 0.07 in the ICM group (P , 0:001 for both groups).
Two/23 (8.6%) patients in the DCM, and 11/67 (16.4%)
patients in the ICM group were in NYHA class III, but all
these patients were in NYHA class IV prior to surgery.
Comparison of preoperative and follow-up echocardio-
graphic and clinical data is shown in Table 2. There was a
significant increase of left ventricular ejection fraction and
decrease of left ventricular volumes in both DCM and ICM
patients 1 year after operation.
Early reoperation for residual mitral regurgitation .3
was necessary in four patients (3.5%). In 1/30 (3.3%)
patients with DCM and in 3/91 (3.3%) with ICM. In one
ICM patient a second reconstruction with a smaller ring was
carried out on the eighth postoperative day. The other
Fig. 1. Actuarial survival of patients with DCM and ICM. () number of pts.
remaining at risk for main intervals analyzed.
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patients received a mitral valve replacement 2, 14 and 95
days after primary surgery.
After 1 year mean postoperative mitral regurgitation was
grade 0.6 in the DCM and grade 1.0 in the ICM group. One
patient in the DCM group (4%) and five patients in the ICM
group (7%) showed mitral insufficiency grade 3. The risk
factors for mitral insufficiency $2 were preoperative
NYHA-class IV ðP ¼ 0:3Þ and larger annuloplasty ring
size ðP ¼ 0:02Þ in patients with DCM. The presence of
posterior infarction ðP ¼ 0:025Þ, lower preoperative ejec-
tion fraction ðP ¼ 0:043Þ and larger ring size ðP ¼ 0:026Þ
were risk factors for mitral insufficiency $ 2 in patients
with ICM.
4. Discussion
Mitral regurgitation is a poor prognostic sign for patients
with severe left ventricular dysfunction. Blondheim [3]
studied 91 patients with dilated cardiomyopathy and
demonstrated a significantly decreased 2-year survival in
patients with mitral regurgitation compared to those with
preserved mitral valve function. In addition, Anquita [8]
was able to correlate long-term survival with left ventricular
ejection fraction less than 30%, episodes of temporary
cardiac decompensation, and increased left ventricular end-
diastolic volume demonstrating limited survival and treat-
ment options in this group of patients. Cardiac transplan-
tation is one option for symptomatic and treatment-
refractory patients with mitral regurgitation in the presence
of severe left ventricular dysfunction, but it is hindered by
donor organ shortage, and more important, through its
limited applicability to older patients presenting with
extracardiac co-morbidities. Finally, mitral valve replace-
ment has not been routinely performed in this group of
patients because of the presumed prohibitive operative
mortality [9–11].
Studies by Hansen [12] and Saris et al. [13] using load-
independent measurement of left ventricular contractility,
demonstrate that division of all chordae tendineae was
accompanied by a 47% reduction in maximal left ventricular
elastance. Further, the effects of chordal detachment and
reattachment on left ventricular function were assessed by
load-independent measurements of maximal elastance. If all
chordae were detached, a significant decline of left
ventricular contractility was seen, which was subsequently
restored to baseline levels after the native chordae were
reattached by repair of the papillary muscles. Thus,
reconstruction of the mitral valve with preservation of
annular–chordal–papillary muscle continuity [14] results in
maintenance of LV systolic function, lower LV volumes, and
less end-systolic wall stress [15,16] and has a lower mortality
than mitral valve replacement [17]. Bolling [1] hypothesised
that correction of mitral regurgitation through valve repair
may stabilise or improve cardiac pump function by
eliminating mitral regurgitation while preserving the mitral
annulus–chordae–papillary continuity shown to be necess-
ary for optimal left ventricular function and geometry.
In our patients, severe left ventricular dysfunction and
mitral regurgitation would be predictive for a limited short-
term survival. Nevertheless, mitral annuloplasty using a
flexible posterior ring proved to be superior to results
published with medical treatment alone as well as to those
after cardiac transplantation. Besides improved mid-term
survival, mitral valve reconstruction in these high-risk
patients significantly increased functional capacity and
decreased the incidence of repeated hospitalisation for
treatment-refractory congestive heart failure.
Early mortality rate was 6.6% in our patients. Others
published mortality rates of 9.2%, respectively 11% [18,19]
in comparable patients. Actuarial survival after 5 years was
around 70% for both DCM and ICM patients. Others have
shown mid-term survival rates of 71% after 2 years [18],
respectively 78% after 5 years [21]. Actuarial survival 5
years after heart transplantation is 68% as stated in the
literature [22]. However, most of our patients were not
candidates for heart transplantation due to age and/or
concomitant diseases.
We found that a larger annuloplasty ring was a risk factor
for overall mortality. Logically, these patients have a greater
chance to develop recurrent mitral insufficiency and it is
clear that prognosis of these patients decreases again. For
this reason we agree with others that it is important to
undersize annuloplasty rings [20]. In recent years we strictly
follow this rule and we have the impression that frequency
of recurrent mitral insufficiency is decreasing. This is
especially true for patients with ICM. In these patients,
downsizing of the mitral annulus as the only surgical step
Table 2
Echocardiographic data preoperatively (PRE) and at 1-year follow-up (FU)
DCM (n ¼ 30) ICM (n ¼ 91)
PRE FU P-value PRE FU P-value
NYHA-Class 3.3 ^ 0.1 1.8 ^ 0.2 0.0000 3.2 ^ 0.04 1.7 ^ 0.07 0.0000
LVEF (%) 23 ^ 1.0 34 ^ 2.7 0.0003 25 ^ 0.5 32 ^ 1.2 0.00001
LVESD (mm) 53 ^ 1.2 46 ^ 2.4 0.03 50 ^ 0.9 47 ^ 1.2 0.04
LVEDD (mm) 65 ^ 1.0 60 ^ 1.7 0.02 64 ^ 0.9 61 ^ 1.0 0.1
LVEF, left ventricular ejection fraction; LVESD, left ventricular endsystolic diameter; LVEDD, left ventricular enddiastolic diameter.
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restored leaflet coaptation eliminating mitral regurgitation
presumably by acute remodelling of the base of the heart.
This may re-establish an ellipsoid shape to the base of left
ventricular cavity causing regression of left ventricular
dimensions.
Larger preoperative left ventricular dimensions were also
risk factors for overall mortality, maybe an indicator for
impossibility of the ventricle to improve after correction of
the mitral insufficiency.
It is striking how symptoms in terms of NYHA
classification improved in both DCM patients and ICM
patients. However, we recognised that not every patient had
a profit from the operation. Unfortunately we could not find
any factors that could predict NYHA-class improvement.
In most patients LVEF increased and left ventricular
dimensions decreased significantly as shown by others [19,
1]. The mechanism of this phenomenon is yet not clear.
Bolling [1] hypothesised the stabilization of the mitral
annulus and LV unloading that has induced a more
favourable ventricular geometry as a postulated mechanism
for the improvement in ventricular function in patients with
end-stage cardiomyopathy undergoing mitral valve recon-
struction. However, coronary artery revascularisation in
patients with ICM certainly helped at least in part to
increase LVEF and decrease LVEDD and LVESD.
Four patients needed early reoperation of the mitral valve
due to recurrent mitral insufficiency. The causes were a too
large ring (32 mm) in one patient, a reoperation on
postoperative day 8 and implantation of a smaller ring
(26 mm) eliminated the problem and the mitral valve was
competent at follow-up. The other reoperations because of
recurrent mitral insufficiency were on postoperative day 2,
14 and 95 in one case because of chordal rupture after
chordal shortening, in the other two cases the leaflets were
altered and a second reconstruction was not possible. After 1
year echocardiography showed recurrent mitral insuffi-
ciency grade III in six patients. Interestingly, all these
patients were satisfied with the result in terms of NYHA
classification, and so a reoperation was not performed.
Increased preoperative left ventricular dimensions and
severely decreased preoperative left ventricular ejection
fraction were significant predictors for recurrent mitral
regurgitation.
5. Study limitations
We are well aware of the fact that the etiologies of the
two cardiomyopathy groups are different. In the ischemic
group coronary bypass grafting and/or left ventricular
aneurysmectomy combined with mitral valve reconstruction
was carried out in most patients. In this group, postoperative
improvement of left ventricular function can be either due to
coronary revascularization or due to mitral valve recon-
struction. However, since most of these patients had
posterior myocardial infarction with necrotic myocardium
the benefit of revascularization is certainly not significant.
An exact preoperative examination of viable myocardium of
posterior wall would be the solution but is not feasible due
to economical reasons.
In conclusion, mitral reconstruction with posterior
flexible ring effectively corrected mitral regurgitation in
patients with severely decreased left ventricular function
due to dilated or ischemic cardiomyopathy. With regard to
the increased surgical risk in patients with end-stage heart
failure and the number of concomitant procedures, the
operative mortality seems to be acceptable. Life quality
improves after surgery due to a significant increase in
exercise capacity. Mid-term results are encouraging and
survival is superior to medical treatment alone and
comparable to cardiac transplantation.
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Appendix A. Conference discussion
Dr R. De Simone (Heidelberg, Germany): You report an acceptable
mortality in this kind of procedure, but you didn’t show us the data about
patients without operation. You know that there is still controversy about
treating these patients or not. Do you have some data of your own or from
the literature?
Dr Szalay: It’s very important to operate on these patients because the
survival in these patients without operation is much worse compared to
patients without operation.
Dr De Simone: But in order to make this statement, you have to
compare, either with the literature or with your own data. If you leave the
patients without the operation, how is the mortality?
Dr Szalay: Actuarial survival after 1 year in patients with a severe
mitral insufficiency and NYHA-Class IV is about 30% without operation.
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